Loading...
•
Sep 30, 2024
Privia Health Q3 2024 Earnings Report
Privia Health's financial performance for Q3 2024 was reported, demonstrating strong execution across business and financial metrics, and full-year 2024 guidance was raised.
Key Takeaways
Privia Health reported a 4.9% increase in total revenue, reaching $437.9 million. The company's adjusted EBITDA grew by 25.8% to $23.6 million, and cash and cash equivalents increased by 27.7% to $422.0 million. They also delivered MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023
Total revenue increased by 4.9% year-over-year to $437.9 million.
Adjusted EBITDA grew by 25.8% year-over-year to $23.6 million.
Cash and cash equivalents increased by 27.7% year-over-year to $422.0 million.
Announced New Market Entry in Indiana
Revenue by Segment
Forward Guidance
Privia Health raised its full-year 2024 guidance to at or above the high end for all metrics.
Positive Outlook
- Implemented Providers: High End
- Attributed Lives: Above High End
- Practice Collections: High End
- GAAP Revenue: High End
- Adjusted EBITDA: High End
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...